We maintain BUY recommendation with the TP to Rs 435/share valuing it at FY24E EPS. The key downside risk to our estimates Uncertainties caused by the sudden resurgence of COVID cases, while an ups...
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.